Rizwana F Sproule Insider Trading
Get free email notifications about insider trading for Rizwana F Sproule.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rizwana F Sproule. Rizwana F Sproule is a VP Regulatory Affairs in Kite Pharma, Inc. ($KITE).
Address: 2225 COLORADO AVENUE SANTA MONICA 90404 CA
Companies in which Rizwana F Sproule is an Insider
Kite Pharma, Inc.
Trading Symbol: KITEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Rizwana F Sproule: VP Regulatory Affairs
Holdings: 10,211 shares
Current Value: $544,451
Latest Transaction: Mar 17 2016
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Rizwana F Sproule
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 8,500 | 11,475 | 95,830 | |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 48.07 | 189 | 9,085 | 10,211 | 10.4 K to 10.2 K (-1.82 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 46.55 | 499 | 23,228 | 10,400 | 10.9 K to 10.4 K (-4.58 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 45.12 | 7,812 | 352,477 | 10,899 | 18.7 K to 10.9 K (-41.75 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 8,500 | 11,475 | 18,711 | 10.2 K to 18.7 K (+83.24 %) |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 104,330 | |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 46.01 | 100 | 4,601 | 8,741 | 8.8 K to 8.7 K (-1.13 %) |